Abstract
Renal transplant is the organ transplant of a kidney into a patient with end-stage kidney disease (ESRD). It is important to regularly monitor the new kidney's function by measuring serum creatinine and other laboratory measurements at least every three months for the rest of the person's life. The pathophysiology underlying bone disorders after transplantation are resulted from a complex interplay of factors. Current review aims to investigate the bone status of the patients after renal transplant by evaluating their physical and clinical bone tests( PTH ,vit D3,ALP,Ca,P,Mg and DEXA scan). The clinical utility of serum markers of bone turnover . para thyroid hormone levels drop by half in the first six months following transplantation, but remain elevated in almost half of kidney transplant patients two years later. Levels of 1,25–dihydroxy vitamin D [1,25(OH)2D] have been linked to improved kidney function. After kidney transplantation, serum calcium generally follows a biphasic pattern. After 3-6 months after transplantation, hypercalcemia has been recorded in about 5%–15% of patients. Hypophosphatemia is frequent in the early post–transplant period, with 50% of acute kidney transplant patients experiencing it.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have